Tag:
Optherion
Latest Headlines
Latest Headlines
Upstart biotech attracts A-list investors
An upstart biotech company focused on developing new therapies targeted at the genetic variations linked to dry age-related macular degeneration has raised $37 million in its first round. New Haven,
